11th Mar 2015 09:46
LONDON (Alliance News) - Vectura Group PLC on Wednesday said its partner has announced the launch of the AirFluSal Forspiro inhaler in Portugal and Ireland.
Vectura said the confirmation of the launch from its licence partner, Sandoz, means the inhaler, which is used by patients with asthma and chronic obstructive pulmonary disease, has now been launched in a dozen European countries.
Vectura shares were up 0.7% to 147.50 pence on Wednesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
VEC.L